Research Integrity

FASEB : OPA : Policy Issues

FASEB Policy Statements

Go Back


>	FASEB Receives Grant to Address Conflicts of Interest July 14, 2006

>	FASEB Thanks NIH and HHS Leaders for Modifications to Conflict Of Interest Rule September 20, 2005

>	FASEB Calls NIH Conflict of Interest Rule ‘Overly Restrictive’ March 29, 2005

>	FASEB President Paul W. Kincade Statement on NIH Conflict of Interest Regulations February 3, 2005

>	FASEB Comments on ORI Notice of Proposed Rule Making June 10, 2004

>	*Scientific Misconduct: ORI Survey is flawed - Nature:* December 19/26, 2002

>	FASEB and AAMC Presidents Warn That Proposed Research Misconduct Survey Unlikely to Produce Useful or Accurate Results November 12, 2002

>	FASEB President Talks About the Importance of Mentoring In Fostering Research Integrity October 10, 2002

>	FASEB Finds ORI's Proposal to Protect Whistleblowers Overly Broad, Too Prescriptive, and Unfair January 29, 2001

>	FASEB Supports Goal of ORI Training Guidelines But Strongly Criticizes its Approach August 11, 2000

>	FASEB Concerned About Balance of Rights between Accused and Accusers July, 1996

>	Letter to the Hon. Donna Shalala Re: Implementation Group Recommendations (Raub Committee) July 2, 1996

>	Coalition of Biological Scientists Meets to Address Report of Commission on Research Integrity June, 1996

>	Report of the DHHS Implementation Group (Raub Report) June 14, 1996

>	Statement by Coalition of Biological Scientists(letter to Raub) May 13, 1996

>	Coalition Press Release May 13, 1996

>	FASEB Urges Cabinet Member to Reject CRI Report February, 1996

>	Letter of Dr. Bradshaw to the Honorable Donna Shalala January, 1996

>	Letter of Dr. Bradshaw to the Commission on Research Integrity September, 1995

The Federation of American Societies for Experimental Biology (FASEB) advances biological science through collaborative advocacy for research policies that promote scientific progress and education and lead to improvements in human health.